Certara is the largest and most comprehensive provider of biosimulation (modeling and simulation), strategic pharmacometrics, and regulatory writing consulting services. Our multidisciplinary team works alongside clients to inform key drug development decisions and expedite the processes around achieving regulatory milestones.
Certara combines its industry renowned pharmacometric and regulatory consultants with our vast software portfolio to provide services that focus on specific outcomes, therapeutic areas, regulatory milestones, and specific populations.
United States: 1-888-708-7444 or 1-919-852-4685
France: +33 1 56 95 17 10
Germany: +49 89 45 10 300
United Kingdom: +44 (0) 114 292 2322
India: +91 984 500 6625
Interested in Certara's biosimulation solutions? Want to speak to someone in our sales team? Click on the link below!
The SYBYL®-X Suite is a complete drug and molecular design environment available, with comprehensive tools for molecular modeling— including small molecule and macromolecular modeling and simulation, cheminformatics, lead identification and lead optimization.
With the SYBYL-X Suite, scientists can:
The SYBYL-X Suite includes all the tools needed for lead identification, lead optimization, and molecular modeling– eliminating the need to make additional purchases.
Visualize and explore relationships between multiple properties with the analysis tools in the Molecular Data Explorer (MDE) in SYBYL-X, and obtain insights into your project in minutes.
SYBYL-X has predictive methods that help researchers identify safety and/or off-target pharmacology earlier to allow chemistry efforts to focus on the areas with the best chance of success. Accurate 3D QSAR models allow researchers to prioritize their ideas and select those most likely to advance project objectives.
The user interface is designed to save time and simplify workflows for molecular modelers.
Learn more about the SYBYL-X Suite: